Skip to main content
All lobbying filings

RK STRATEGIES, INC.

Lobbying for CLEARMIND MEDICINE, INC · Developer of Psychedelics Medicines

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · British Columbia · House · Senate · $10,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 7091
    Expanding Veterans’ Access to Emerging Treatments Act
  • HR 2623
    Innovative Therapies Centers of Excellence Act of 2025
 Lobbying activity 4
Health Issues

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27

Defense

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Alcohol and Drug Abuse

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Veterans

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem